Media Summary: Efficacy and safety of alirocumab in high CV risk patients with inadequately controlled hypercholesterolaemia on maximally ... Alirocumab vs Ezetimibe in patients with statin intolerance. For more resources from the Keystone of Success - Valuable collaboration between the European Society of Cardiology (ESC) and its flagship journal the ...
Ehj Today Odyssey Studies - Detailed Analysis & Overview
Efficacy and safety of alirocumab in high CV risk patients with inadequately controlled hypercholesterolaemia on maximally ... Alirocumab vs Ezetimibe in patients with statin intolerance. For more resources from the Keystone of Success - Valuable collaboration between the European Society of Cardiology (ESC) and its flagship journal the ... Legends in Cardiology - Prof. Marc Pfeffer. For more resources from the Rosk/Benefit of prolonged DAPT after DES. For more resources from the The British Heart Foundation Fractional Flow Reserve versus Angiography in Guiding Management to Optimise Outcomes in ...
In-ambulance vs. in-cath lab administration of ticagrelor in STEMI patients transferred for primary PCI: the randomized, ... Effect of intravenous TRO40303 as an adjunct to PCI for acute STEMI: Results of the MITOCARE Study. Clinical benefit of the safer mode in a mixed dual chamber population: The results from the ANSWER Study. Losartan In Hypertrophic Cardiomyopathy. For more resources from the Ezetimibe/Simvastatin vs Simvastatin monotherapy on cardiovascular outcomes after ACS. For more resources from the Perioperative statin treatment in cardiac surgery for preventing AF and perioperative myocardial damage: The Statin Therapy In ...
S. Taddei, S. Janssens, M. Marber on the NOMI Study NO for inhalation to reduce reperfusion injury in acute STEMI.
